Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACIAM trial of intravenous N-acetylcysteine in STEMI undergoing primary PCI
ACTRN12610000280000Phase 4Completed
- Sponsor
- Queen Elizabeth Hospital
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Intravenous N-acetylcysteine with Saline placebo (2 arms). Primary endpoint: Myocardial infarct size. Started Mar 2010; status: completed.
02
Drugs
acetylcysteine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ACTRN12610000280000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000280000.